Literature DB >> 17712539

[Preoperative risk evaluation in heart failure].

B Cremers1, C Maack, M Böhm.   

Abstract

The primary target in preoperative risk evaluation is not to classify patients as operable or inoperable but rather to reduce perioperative morbidity and mortality. Indications for perioperative diagnostic and therapeutic procedures are mostly the same as for patients without subsequent non-cardiac surgery. However, the time schedule often depends on cofactors such as urgency and severity of surgical interventions. Perioperative risk management requires exceedingly good communication and collaboration between surgeons, anesthesiologists and internists and offers the chance to diagnose and treat perioperative risk factors in a justifiable time and cost context.

Entities:  

Mesh:

Year:  2007        PMID: 17712539     DOI: 10.1007/s00108-007-1911-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  27 in total

1.  Perioperative beta-blocker withdrawal and mortality in vascular surgical patients.

Authors:  J B Shammash; J C Trost; J M Gold; J A Berlin; M A Golden; S E Kimmel
Journal:  Am Heart J       Date:  2001-01       Impact factor: 4.749

2.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

3.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.

Authors:  James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

Review 4.  Preoperative evaluation for major noncardiac surgery: focusing on heart failure.

Authors:  Adrian F Hernandez; L Kristin Newby; Christopher M O'Connor
Journal:  Arch Intern Med       Date:  2004-09-13

5.  ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliott Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-06-06       Impact factor: 29.690

6.  Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery.

Authors:  K A Eagle; B H Brundage; B R Chaitman; G A Ewy; L A Fleisher; N R Hertzer; J A Leppo; T Ryan; R C Schlant; W H Spencer; J A Spittell; R D Twiss; J L Ritchie; M D Cheitlin; T J Gardner; A Garson; R P Lewis; R J Gibbons; R A O'Rourke; T J Ryan
Journal:  Circulation       Date:  1996-03-15       Impact factor: 29.690

7.  Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.

Authors:  Harm H H Feringa; Olaf Schouten; Martin Dunkelgrun; Jeroen J Bax; Eric Boersma; Abdou Elhendy; Robert de Jonge; Stefanos E Karagiannis; Radosav Vidakovic; Don Poldermans
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

8.  Assessment of perioperative cardiac risk.

Authors:  L Goldman
Journal:  N Engl J Med       Date:  1994-03-10       Impact factor: 91.245

9.  Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.

Authors:  J R Balser; E A Martinez; B D Winters; P W Perdue; A W Clarke; W Huang; G F Tomaselli; T Dorman; K Campbell; P Lipsett; M J Breslow; B A Rosenfeld
Journal:  Anesthesiology       Date:  1998-11       Impact factor: 7.892

Review 10.  An epidemic of heart failure? Recent evidence from Europe.

Authors:  A W Hoes; A Mosterd; D E Grobbee
Journal:  Eur Heart J       Date:  1998-10       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.